Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Destination Joint Spacers, Reinfection, and Antimicrobial Suppression.

Valencia JCB, Abdel MP, Virk A, Osmon DR, Razonable RR.

Clin Infect Dis. 2019 Aug 30;69(6):1056-1059. doi: 10.1093/cid/ciz062.

PMID:
30689767
2.

Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Valencia JC, Egbukichi N, Erwin-Cohen RA.

J Interferon Cytokine Res. 2019 Jan;39(1):72-84. doi: 10.1089/jir.2018.0060. Epub 2018 Dec 18.

PMID:
30562133
3.

The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity.

Bae HR, Hodge DL, Yang GX, Leung PSC, Chodisetti SB, Valencia JC, Sanford M, Fenimore JM, Rahman ZSM, Tsuneyama K, Norman GL, Gershwin ME, Young HA.

Hepatology. 2018 Apr;67(4):1408-1419. doi: 10.1002/hep.29524. Epub 2018 Feb 18.

4.

Current prospects of type II interferon γ signaling and autoimmunity.

Green DS, Young HA, Valencia JC.

J Biol Chem. 2017 Aug 25;292(34):13925-13933. doi: 10.1074/jbc.R116.774745. Epub 2017 Jun 26. Review.

5.

Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance.

Bae HR, Leung PS, Tsuneyama K, Valencia JC, Hodge DL, Kim S, Back T, Karwan M, Merchant AS, Baba N, Feng D, Park O, Gao B, Yang GX, Gershwin ME, Young HA.

Hepatology. 2016 Oct;64(4):1189-201. doi: 10.1002/hep.28641. Epub 2016 Jun 15.

6.

Identification of Genes Expressed in Hyperpigmented Skin Using Meta-Analysis of Microarray Data Sets.

Yin L, Coelho SG, Valencia JC, Ebsen D, Mahns A, Smuda C, Miller SA, Beer JZ, Kolbe L, Hearing VJ.

J Invest Dermatol. 2015 Oct;135(10):2455-2463. doi: 10.1038/jid.2015.179. Epub 2015 Jun 7.

7.

NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.

Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ.

Cancer Res. 2015 Jul 1;75(13):2708-15. doi: 10.1158/0008-5472.CAN-13-3209. Epub 2015 Apr 1.

8.

Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4.

Kondo T, Namiki T, Coelho SG, Valencia JC, Hearing VJ.

J Dermatol Sci. 2015 Jan;77(1):21-7. doi: 10.1016/j.jdermsci.2014.11.006. Epub 2014 Nov 20.

PMID:
25530116
9.

UV exposure modulates hemidesmosome plasticity, contributing to long-term pigmentation in human skin.

Coelho SG, Valencia JC, Yin L, Smuda C, Mahns A, Kolbe L, Miller SA, Beer JZ, Zhang G, Tuma PL, Hearing VJ.

J Pathol. 2015 May;236(1):17-29. doi: 10.1002/path.4497. Epub 2015 Feb 17.

10.

Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.

Valencia JC, Steagall WK, Zhang Y, Fetsch P, Abati A, Tsukada K, Billings E, Hearing VJ, Yu ZX, Pacheco-Rodriguez G, Moss J.

Chest. 2015 Mar;147(3):771-777. doi: 10.1378/chest.14-0380.

11.

Essential role of the molecular chaperone gp96 in regulating melanogenesis.

Zhang Y, Helke KL, Coelho SG, Valencia JC, Hearing VJ, Sun S, Liu B, Li Z.

Pigment Cell Melanoma Res. 2014 Jan;27(1):82-9. doi: 10.1111/pcmr.12165. Epub 2013 Oct 9.

12.

Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes.

Kawaguchi M, Valencia JC, Namiki T, Suzuki T, Hearing VJ.

J Invest Dermatol. 2012 Dec;132(12):2791-9. doi: 10.1038/jid.2012.261. Epub 2012 Aug 16.

13.

AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.

Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L, Polley EC, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H, Hearing VJ.

Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6597-602. doi: 10.1073/pnas.1007694108. Epub 2011 Apr 1.

14.

Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma.

Chen KG, Valencia JC, Gillet JP, Hearing VJ, Gottesman MM.

Pigment Cell Melanoma Res. 2009 Dec;22(6):740-9. doi: 10.1111/j.1755-148X.2009.00630.x. Epub 2009 Aug 29. Review.

15.

Influence of melanosome dynamics on melanoma drug sensitivity.

Chen KG, Leapman RD, Zhang G, Lai B, Valencia JC, Cardarelli CO, Vieira WD, Hearing VJ, Gottesman MM.

J Natl Cancer Inst. 2009 Sep 16;101(18):1259-71. doi: 10.1093/jnci/djp259. Epub 2009 Aug 24.

16.

Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi.

Sánchez-Laorden BL, Herraiz C, Valencia JC, Hearing VJ, Jiménez-Cervantes C, García-Borrón JC.

J Cell Physiol. 2009 Sep;220(3):640-54. doi: 10.1002/jcp.21804.

17.

Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.

Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y, Hearing VJ.

J Clin Invest. 2009 Apr;119(4):954-63. doi: 10.1172/JCI34015. Epub 2009 Mar 9.

18.

Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r.

Le Pape E, Passeron T, Giubellino A, Valencia JC, Wolber R, Hearing VJ.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1802-7. doi: 10.1073/pnas.0806753106. Epub 2009 Jan 27.

19.

Evidence for the ectopic synthesis of melanin in human adipose tissue.

Randhawa M, Huff T, Valencia JC, Younossi Z, Chandhoke V, Hearing VJ, Baranova A.

FASEB J. 2009 Mar;23(3):835-43. doi: 10.1096/fj.08-116327. Epub 2008 Oct 29.

20.

A novel approach to enhance antibody sensitivity and specificity by peptide cross-linking.

Namiki T, Valencia JC, Hall MD, Hearing VJ.

Anal Biochem. 2008 Dec 15;383(2):265-9. doi: 10.1016/j.ab.2008.08.024. Epub 2008 Aug 30.

21.

Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial.

De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, Bedoya M, Toro JM, Velásquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA; Grupo de Investigacion en Cuidado intensivo: GICI-HPTU.

Crit Care. 2008;12(5):R120. doi: 10.1186/cc7017. Epub 2008 Sep 17.

22.

Isolation of melanosomes.

Watabe H, Kushimoto T, Valencia JC, Hearing VJ.

Curr Protoc Cell Biol. 2005 Apr;Chapter 3:Unit 3.14. doi: 10.1002/0471143030.cb0314s26.

PMID:
18228474
23.

SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation.

Passeron T, Valencia JC, Bertolotto C, Hoashi T, Le Pape E, Takahashi K, Ballotti R, Hearing VJ.

Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13984-9. Epub 2007 Aug 16.

24.

Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking.

Watabe H, Valencia JC, Le Pape E, Yamaguchi Y, Nakamura M, Rouzaud F, Hoashi T, Kawa Y, Mizoguchi M, Hearing VJ.

J Invest Dermatol. 2008 Jan;128(1):162-74. Epub 2007 Aug 9.

25.

Comparative Bioinformatics Analyses and Profiling of Lysosome-Related Organelle Proteomes.

Hu ZZ, Valencia JC, Huang H, Chi A, Shabanowitz J, Hearing VJ, Appella E, Wu C.

Int J Mass Spectrom. 2007 Jan 1;259(1-3):147-160.

26.

Sialylated core 1 O-glycans influence the sorting of Pmel17/gp100 and determine its capacity to form fibrils.

Valencia JC, Rouzaud F, Julien S, Chen KG, Passeron T, Yamaguchi Y, Abu-Asab M, Tsokos M, Costin GE, Yamaguchi H, Jenkins LM, Nagashima K, Appella E, Hearing VJ.

J Biol Chem. 2007 Apr 13;282(15):11266-80. Epub 2007 Feb 15.

27.

Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

Chi A, Valencia JC, Hu ZZ, Watabe H, Yamaguchi H, Mangini NJ, Huang H, Canfield VA, Cheng KC, Yang F, Abe R, Yamagishi S, Shabanowitz J, Hearing VJ, Wu C, Appella E, Hunt DF.

J Proteome Res. 2006 Nov;5(11):3135-44.

PMID:
17081065
28.

Regulation of constitutive and UVR-induced skin pigmentation by melanocortin 1 receptor isoforms.

Rouzaud F, Costin GE, Yamaguchi Y, Valencia JC, Berens WF, Chen KG, Hoashi T, Böhm M, Abdel-Malek ZA, Hearing VJ.

FASEB J. 2006 Sep;20(11):1927-9. Epub 2006 Jul 28.

PMID:
16877522
29.

Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.

Chen KG, Valencia JC, Lai B, Zhang G, Paterson JK, Rouzaud F, Berens W, Wincovitch SM, Garfield SH, Leapman RD, Hearing VJ, Gottesman MM.

Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9903-7. Epub 2006 Jun 15.

30.

Pmel17: controversial indeed but critical to melanocyte function.

Valencia JC, Hoashi T, Pawelek JM, Solano F, Hearing VJ.

Pigment Cell Res. 2006 Jun;19(3):250-2; author reply 253-7. No abstract available.

PMID:
16704461
31.

Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes.

Valencia JC, Watabe H, Chi A, Rouzaud F, Chen KG, Vieira WD, Takahashi K, Yamaguchi Y, Berens W, Nagashima K, Shabanowitz J, Hunt DF, Appella E, Hearing VJ.

J Cell Sci. 2006 Mar 15;119(Pt 6):1080-91. Epub 2006 Feb 21.

32.

Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.

Valencia JC, Pacheco-Rodriguez G, Carmona AK, Xavier J, Bruneval P, Riemenschneider WK, Ikeda Y, Yu ZX, Ferrans VJ, Moss J.

Am J Respir Cell Mol Biol. 2006 Jul;35(1):40-7. Epub 2006 Feb 10.

33.

Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitin-proteasome pathway.

Ando H, Wen ZM, Kim HY, Valencia JC, Costin GE, Watabe H, Yasumoto K, Niki Y, Kondoh H, Ichihashi M, Hearing VJ.

Biochem J. 2006 Feb 15;394(Pt 1):43-50.

34.

Different approaches for assaying melanosome transfer.

Berens W, Van Den Bossche K, Yoon TJ, Westbroek W, Valencia JC, Out CJ, Marie Naeyaert J, Hearing VJ, Lambert J.

Pigment Cell Res. 2005 Oct;18(5):370-81.

35.

Mutations in dopachrome tautomerase (Dct) affect eumelanin/pheomelanin synthesis, but do not affect intracellular trafficking of the mutant protein.

Costin GE, Valencia JC, Wakamatsu K, Ito S, Solano F, Milac AL, Vieira WD, Yamaguchi Y, Rouzaud F, Petrescu AJ, Lamoreux ML, Hearing VJ.

Biochem J. 2005 Oct 15;391(Pt 2):249-59.

36.

Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes.

Chen KG, Szakács G, Annereau JP, Rouzaud F, Liang XJ, Valencia JC, Nagineni CN, Hooks JJ, Hearing VJ, Gottesman MM.

Pigment Cell Res. 2005 Apr;18(2):102-12.

37.

Immortalization of mouse melanocytes carrying mutations in various pigmentation genes.

Costin GE, Vieira WD, Valencia JC, Rouzaud F, Lamoreux ML, Hearing VJ.

Anal Biochem. 2004 Dec 1;335(1):171-4. No abstract available.

PMID:
15519586
38.

Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment.

Yasumoto K, Watabe H, Valencia JC, Kushimoto T, Kobayashi T, Appella E, Hearing VJ.

J Biol Chem. 2004 Jul 2;279(27):28330-8. Epub 2004 Apr 19.

39.

Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function.

Ando H, Watabe H, Valencia JC, Yasumoto K, Furumura M, Funasaka Y, Oka M, Ichihashi M, Hearing VJ.

J Biol Chem. 2004 Apr 9;279(15):15427-33. Epub 2004 Jan 22.

40.

Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.

Watabe H, Valencia JC, Yasumoto K, Kushimoto T, Ando H, Muller J, Vieira WD, Mizoguchi M, Appella E, Hearing VJ.

J Biol Chem. 2004 Feb 27;279(9):7971-81. Epub 2003 Nov 21.

41.

Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist.

Rouzaud F, Annereau JP, Valencia JC, Costin GE, Hearing VJ.

FASEB J. 2003 Nov;17(14):2154-6. Epub 2003 Sep 18.

PMID:
14500544
42.
43.

The Seiji memorial lecture: the melanosome: an ideal model to study cellular differentiation.

Kushimoto T, Valencia JC, Costin GE, Toyofuku K, Watabe H, Yasumoto K, Rouzaud F, Vieira WD, Hearing VJ.

Pigment Cell Res. 2003 Jun;16(3):237-44.

PMID:
12753396
44.

The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.

Toyofuku K, Valencia JC, Kushimoto T, Costin GE, Virador VM, Vieira WD, Ferrans VJ, Hearing VJ.

Pigment Cell Res. 2002 Jun;15(3):217-24. Erratum in: Pigment Cell Res. 2002 Oct;15(5):400..

PMID:
12028586
45.

Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.

Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ, Hearing VJ.

FASEB J. 2001 Oct;15(12):2149-61.

PMID:
11641241
46.

Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis.

Valencia JC, Matsui K, Bondy C, Zhou J, Rasmussen A, Cullen K, Yu ZX, Moss J, Ferrans VJ.

J Investig Med. 2001 Sep;49(5):421-33. doi: 10.2310/6650.2001.33787.

PMID:
11523698
47.

Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.

Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, Riemenschn W, Matsui K, Travis WD, Moss J.

J Nippon Med Sch. 2000 Oct;67(5):311-29. Review.

48.

[Role of laminar culture in the diagnosis of urinary infection].

Uribe L, Valencia JC, Quintana JM, Etxebarria M, Letona J.

Aten Primaria. 1990 Apr;7(4):332-3. Spanish. No abstract available.

PMID:
2102766

Supplemental Content

Loading ...
Support Center